iRay Group (SHA:688301)
116.10
-1.98 (-1.68%)
May 8, 2026, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 24.54 billion as of May 8, 2026. Its market cap has increased by 40.54% in one year.
Market Cap
24.54B
Enterprise Value
25.95B
Revenue
2.46B
Ranking
n/a
PE Ratio
36.30
Stock Price
116.10
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 24.54B, an increase of 111.27%. That is a compound annual growth rate of 14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 24.54B | 14.91% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 35.21B |
| Imeik Technology Development | 34.88B |
| Intco Medical Technology | 34.56B |
| Andon Health | 30.34B |
| Zhende Medical | 24.60B |
| Winner Medical | 18.62B |
| Shenyang Xingqi Pharmaceutical | 17.18B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.59B |